Development of Karo Bio towards Clinical Trials
September 13, 2004 04:06 ET
|
Karo Bio
HUDDINGE, Sweden, Sept. 13, 2004 (PRIMEZONE) -- Karo Bio's research operations have been re-engineered in 2004 by strengthening of the efforts in pharmacology and chemistry. With Karo Bio's expressed...
Special General Meeting of The Shareholders of Karo Bio
August 30, 2004 11:01 ET
|
Karo Bio
HUDDINGE, Sweden, Aug. 30, 2004 (PRIMEZONE) -- At Karo Bio AB's special general meeting on Monday August 30, 2004 the following was resolved.
Approval of decisions on New Share Issue
The special...
Karo Bio -- Notice of Special General Meeting of the Shareholders of Karo Bio
August 16, 2004 02:35 ET
|
Karo Bio
HUDDINGE, Sweden, Aug. 16, 2004 (PRIMEZONE) -- A special general meeting of the shareholders of Karo Bio Aktiebolag (publ) will be held on Monday August 30, 2004 at 4.00 pm in Strindbergsalen at...
Karo Bio -- Quarterly Report April-June 2004
July 13, 2004 02:36 ET
|
Karo Bio
HUDDINGE, Sweden, July 13, 2004 (PRIMEZONE) -- Karo Bio:
-- Predevelopment candidate was identified in the Wyeth Pharmaceuticals
collaboration yielding milestone revenues for Karo Bio....
Karo Bio and Wyeth Extend Research Collaboration and Advance Lead Compound
June 18, 2004 02:38 ET
|
Karo Bio
HUDDINGE, Sweden, June 18, 2004 (PRIMEZONE) -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), has advanced into predevelopment a lead compound for atherosclerosis from the joint collaboration...
Bristol-Myers Squibb returns compound rights to Karo Bio
April 30, 2004 02:57 ET
|
Karo Bio
HUDDINGE, Sweden, April 30, 2004 (PRIMEZONE) -- In the fall of 1997 Karo Bio and Bristol-Myers Squibb (BMS) initiated a drug discovery collaboration with the aim to develop novel treatments for...
Karo Bio Quarterly Report January-March 2004
April 23, 2004 02:35 ET
|
Karo Bio
HUDDINGE, Sweden, April 23, 2004 (PRIMEZONE) -- Karo Bio:
-- Substantial progress has been made in the collaboration with Wyeth
Pharmaceuticals in the discovery of lead compounds that show...
Karo Bio's Annual General Meeting
April 22, 2004 02:35 ET
|
Karo Bio
HUDDINGE, Sweden, April 22, 2004 (PRIMEZONE) -- At Karo Bio AB's Annual General Meeting on Wednesday April 21, 2004, the following was resolved. Dividend No dividend is to be paid for the financial...
Karo Bio: Full Year Report 2003 Quarterly Report October-December 2003
February 06, 2004 05:48 ET
|
Karo Bio
HUDDINGE, Sweden, Feb. 06, 2004 (PRIMEZONE) -- Karo Bio:
- A preclinical milestone for a second compound was reached and a milestone payment was received in May in the Merck & Co., Inc....
Karo Bio Will Consolidate Research Operations to Sweden
November 18, 2003 02:43 ET
|
Karo Bio
HUDDINGE, Sweden, Nov. 18, 2003 (PRIMEZONE) -- Karo Bio has decided to reduce its presence in North Carolina USA. Technologies, key projects and other research activities will be transferred...